Literature DB >> 4052424

Influence of glycolipids on immune reactions of phospholipid antigens in liposomes.

S Shichijo, C R Alving.   

Abstract

Complement-dependent immune damage to liposomes mediated by a murine monoclonal antibody to the liposomal bilayer was completely inhibited by ceramide tetrasaccharide (globoside) at an 8% concentration in the liposomes. Lower concentrations of globoside, or higher concentrations of ceramide tri-, di-, or monohexoside, were not inhibitory. At a globoside concentration of 5.8%, inhibition of the monoclonal antibody activity was reduced and inhibition was related to antibody concentration; but at 2% globoside, suppression of antibody activity was not observed at all. Analysis of space-filling models revealed that at 8% globoside the distance between adjacent tetrasaccharides of globoside approached the dimensions of the antigen-binding end of a 7S immunoglobulin molecule. We therefore propose that globoside, and perhaps other glycolipids, can exert steric hindrance to the binding of extracellular proteins to nonglycolipid constituents of the lipid bilayer. We conclude that microheterogeneity among polar groups of glycolipids may be a novel mechanism for allowing selective access of proteins to phospholipids on the lipid bilayer.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4052424     DOI: 10.1016/0005-2736(85)90123-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Anticardiolipin antibody in Henoch-Schönlein purpura and related vascular disorders.

Authors:  I Katayama; M Masuzawa; K Nishioka; S Nishiyama
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

2.  Phase Partitioning of GM1 and Its Bodipy-Labeled Analog Determine Their Different Binding to Cholera Toxin.

Authors:  Sami Rissanen; Michal Grzybek; Adam Orłowski; Tomasz Róg; Oana Cramariuc; Ilya Levental; Christian Eggeling; Erdinc Sezgin; Ilpo Vattulainen
Journal:  Front Physiol       Date:  2017-05-09       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.